Consumer Information Leaflet

OXANDRO®

Oxandrolone
10 mg
100 tablets

Retail Price: 70.00 Interested in Wholesale Pricing?

Available!
POPULARITY
STRENGHT
WEIGHT GAIN
FAT/WATER LOSS
ANTIESTROGEN
SIDE EFFECTS
KEEP GAINS
USAGE
Oral
Consumer Information Leaflet

Why You Should Buy OXANDRO® (Oxandrolone) at FULMEN Pharma?

Here at FULMEN Pharma every single day we strive to deliver immaculate German quality anabolic steroids and HGH for our valued customer by ensuring uninterrupted human eye control on all the processes, post-production tests and examinations followed by a strict each product inspection before shipment. We are absolutely confident about your OXANDRO® (Oxandrolone) product satisfaction and online shopping experience!

About OXANDRO® (Oxandrolone) Product

Oxandrolone just like every other androgen and anabolic steroid (AAS) in the market, is being sold under different brand names such as Anavar and Oxandrin. These medications have been used in the promotion of weight gain, assisting in offsetting protein catabolism which could have been caused by long-term corticosteroid therapy, recovery from severe burns and in the treatment osteoporosis induced bone pains. It has also been used as an aid in the development of girls suffering from Turner’s syndrome. Oxandrolone is administered orally.

The use of Oxandrolone was first mentioned in 1962, and it was accepted for medical use in 1964. Since then, it has been used in the United States in the improvement of physique and performance by bodybuilders and athletes. Due to the level of abuse the drug faced in the general market, its administration, Oxandrolone is now a controlled substance in many countries, and this has made its non-medical use as illicit except when prescribed by a doctor.

Several athletes and bodybuilders prefer to use oxandrolone due to its muscle-building effects. The steroid elicits more of anabolic than androgenic effects thus making it useful even to women who are seeking less intense steroid regimens. Oxandrolone also has a low level of hepatotoxicity which makes is one of the most orally active AAS in the market.

OXANDRO® (Oxandrolone) is produced as a synthetic steroid which elicits similar effect to the naturally occurring steroids. It has been known to promote muscle and tissue growth. It serves as an agonist of the androgen receptor (AR) and increases the rate of protein synthesis which in turn, translates into bone mineral density, lean body mass, and muscle growth. When compared to testosterone, and other AAS available in the market, oxandrolone has a less androgenic activity relative to its strength as an anabolic. It also elicits a reduced androgenic activity, and this is one of the factors that encourage its use among women and children since it brings about a lesser risk of virilization. This advantage is also considered by the bodybuilding community whenever they are choosing AAS.

OXANDRO® (Oxandrolone) is not potentiated in the androgenic tissues such as a prostate gland, hair follicles, and the skin. It brings about an increase in the ratio of anabolic to androgenic activities when compared with testosterone. It comes with no propensity to produce any form of estrogenic effects and does not possess any progestogenic activity which is worthy of note. It is orally active in humans and thus, the reason why it is made available in tablets and not injections like other AAS.

The major side reactions experienced while using Oxandrolone include male-like symptoms such as increased sexual desire, voice changes, increased hair growth, and acne. Since it is administered orally, it has a lesser risk of liver damage. It comes in handy in assisting individuals to regain weight which was lost after surgery and helps in the recovery from chronic infections and trauma.

In summary, each bottle of OXANDRO® (Oxandrolone) contains 100 tablets with a concentration of 10 mg of the substance. Dosage is determined by the physician after taking into cognizance some vital health issues in the body.

More
HAPPY CUSTOMERS GALLERY
Received in Sweden
March 6, 2019
Received in Germany
January 20, 2019
Received in Italy
January 5, 2019
Received in United Kingdom
December 18, 2018
Received in Norway
November 13, 2018
Received in United States
October 21, 2018

FIND US ON